Clinical Trials for Disease-Modifying Therapies in Alzheimer’s Disease: A Primer, Lessons Learned, and a Blueprint for the Future

Jeffrey Cummings, Aaron Ritter, Kate Zhong
  • Journal of Alzheimer s Disease, June 2018, IOS Press
  • DOI: 10.3233/jad-179901
The author haven't finished explaining this publicationThe author haven't finished explaining this publication
Read Publication

http://dx.doi.org/10.3233/jad-179901

The following have contributed to this page: jeffrey cummings

In partnership with: